Hema Now | Episode 6
This week, Jonathan is joined by David Gómez-Almaguer, Head of the Haematology Service at University Hospital Monterrey, Mexico. They discuss advancements in stem cell transplantation, the state of haematology in Latin America, and the future of innovative therapies in the field.
Spotify | Apple | Amazon Music | Download MP3 (29:56 mins)
David Gómez-Almaguer is the Head of the Haematology Service at the University Hospital in Monterrey, Mexico, and the Director of the Stem Cell Transplantation Program, the only FACT-accredited program in the country. He obtained his medical degree degree from the University of Nuevo León in Monterrey and completed his training in haematology and internal medicine at the Instituto Nacional de Nutrición y Ciencias Médicas Salvador Zubirán in Mexico City.
Gómez-Almaguer has an extensive research portfolio, having published over 308 articles in peer-reviewed international journals and several book chapters, with a focus on stem cell transplantation.
- 00:00 – Introduction
- 01:16 – David’s hobby: playing in a rock band
- 03:06 – How David began in haematology
- 04:35 – Stem cell transplantation and therapies
- 06:27 – CAR-T cells
- 07:35 – New treatments for aplastic anaemia, chronic lymphocytic leukaemia, and myelodysplastic syndrome
- 10:54 – Recent clinical trial for Philadelphia positive acute lymphoblastic leukaemia
- 12:55 – The current status of cord blood donation
- 16:08 – Impact of race and ethnicity on outcomes after umbilical cord transplantation
- 16:58 – The effect of resource and budget constraints on healthcare quality
- 23:20 – Novel developments in diagnosis and treatments in haematology
